Haffkine Biopharma to produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with help from the Centre. As part of this initiative, three public enterprises are being supported by the Department of Biotechnology under Atmanirbhar Bharat 3.0 Mission Covid Suraksha.
- Read more about Haffkine Biopharma to produce Covaxin under technology transfer
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/haffkine-biopharma-to-produce-covaxin-under-technology-transfer
No comments:
Post a Comment